Urgent Notice: Join Class Action Against Hims & Hers Health, Inc. Now

Overview of the Class Action Lawsuit

On July 18, 2025, Levi & Korsinsky, LLP announced a class action securities lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) aimed at recovering losses incurred by investors between April 29, 2025, and June 23, 2025. This legal action has been initiated due to allegations of securities fraud that potentially misled investors about the company's operations and business integrity. In a market where trust is paramount, allegations like these could significantly impact investor confidence and stock performance.

Details of the Case

The lawsuit claims that during the relevant period, Hims & Hers Health made misleading statements and concealed critical information regarding its business practices. Specifically, it asserts that the company engaged in deceptive promotion and marketing of counterfeit versions of a well-known weight management drug, Wegovy®, jeopardizing patient safety. Furthermore, there were serious implications regarding a collaboration with Novo Nordisk due to these actions, which raised substantial risk of termination. As a result, positive assertions by the company concerning its business and growth prospects were claimed to be materially misleading, lacking a reasonable basis. These claims encapsulate serious concerns that investors must consider as the case unfolds.

Know Your Rights

Investors who have suffered losses during the aforementioned time frame are encouraged to act swiftly. The deadline to request lead plaintiff status is August 25, 2025. It’s essential to note that even if one does not want to serve as a lead plaintiff, participating in the class action can still afford you the opportunity to benefit from any potential recovery. Moreover, there are no out-of-pocket costs for class members, allowing investors to participate without financial burden.

Why Choose Levi & Korsinsky?

The law firm, Levi & Korsinsky, boasts a track record of achieving over hundreds of millions in recoveries for aggrieved shareholders over the last 20 years. With a dedicated team of over 70 legal professionals specialized in complex securities litigation, they have established a reputation for excellence in high-stakes cases. For seven consecutive years, they have been recognized among the Top 50 securities litigation firms in the United States by ISS Securities Class Action Services, celebrating their commitment to advocating for investor rights.

Steps Forward for Interested Investors

If you believe you are eligible to join or want to seek more information about the class action against Hims & Hers Health, legal counsel is readily available. You may contact Joseph E. Levi, Esq. via email at email protected] or by phone at (212) 363-7500. Additionally, further details can be obtained by following the official submission link: [Hims & Hers Class Action Submission Form.

Conclusion

The unfolding class action against Hims & Hers Health, Inc. presents a crucial opportunity for affected investors to stand up for their rights. As the October deadline approaches, prompt action can secure a position in this significant legal proceeding. Stay informed, vigilant, and proactive to ensure that your interests are thoroughly represented in the changing landscape of corporate governance and investor protection.